- ACTIVE INGREDIENT
- INACTIVE INGREDIENT
- PURPOSE
-
WARNINGS
WARNINGS:
If side-effects, such as redness, itching or swelling occur, discontinue use. If airritation continues after discontinuing use, consult a dermatologist.
1. If a red area develops using this product or there is swelling or itchyness, consult a dermatologist.
2. Exposure to direct sunlight may cause side-effects as above.
3. Do not apply product to an area of skin that is affected by eczema or dermatitis.
4. Wash eyes immediately and thoroughly if product enters eyes. - KEEP OUT OF REACH OF CHILDREN
- INDICATIONS & USAGE
- DOSAGE & ADMINISTRATION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
DAMOAE THERAPY TONIC
salicylic acid solutionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:76081-020 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 2.4 mL in 120 mL Inactive Ingredients Ingredient Name Strength LEVOMENTHOL (UNII: BZ1R15MTK7) FALLOPIA MULTIFLORA ROOT (UNII: AUZ3VD75MC) OENOTHERA BIENNIS (UNII: 76UI55V071) ALOE VERA LEAF (UNII: ZY81Z83H0X) PEPPERMINT OIL (UNII: AV092KU4JH) ALCOHOL (UNII: 3K9958V90M) WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:76081-020-01 120 mL in 1 CARTON Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part358H 09/01/2011 Labeler - DUALLIFE CO., LTD. (690403832) Registrant - DUALLIFE CO., LTD. (690403832) Establishment Name Address ID/FEI Business Operations DUALLIFE CO., LTD. 690403832 manufacture